We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Ian Neeland, MD

Ian Neeland, MD

Office Locations

UH Otis Moss Jr Health Center (1 mi.)

8819 Quincy Ave
Ste 206
Cleveland, OH 44106
216-721-2100

UH Minoff Health Center at Chagrin Highlands (7 mi.)

3909 Orange Pl
Ste 3300
Beachwood, OH 44122
216-844-3800

UH Westlake Health Center (15 mi.)

960 Clague Rd
Ste 2300
Westlake, OH 44145
440-250-2060

UH Twinsburg Health Center (16 mi.)

8819 Commons Blvd
Ste 203
Twinsburg, OH 44087
330-486-9688

Biography: Ian Neeland, MD

Expertise

  • Cardiovascular Diseases
  • Diabetic Cardiology
  • Echocardiography
  • Preventive Cardiology

Titles

  • Director, Center for Cardiovascular Prevention, Harrington Heart and Vascular Institute, University Hospitals
  • Co-Director, Center for Integrated and Novel Approaches in Vascular Metabolic Disease, Harrington Heart and Vascular Institute, University Hospitals
  • Director, Translational Science Unit, Harrington Heart and Vascular Institute, University Hospitals
  • Associate Professor, CWRU School of Medicine

Certifications & Memberships

  • Cardiovascular Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Fellowship | Cardiovascular Disease
Cardiovascular Disease - University Of Texas Southwestern Medical Center (2011 - 2015)

Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - Emory University Hospital (2010 - 2011)

Residency | Internal Medicine
Internal Medicine - Emory University Hospital (2007 - 2010)

Medical Education
Icahn School Of Medicine At Mount Sinai (2007)

Undergraduate
University Of Pennsylvania (2002)

About

View Provider’s Blog

Watch Provider’s Health Talks


Ian J. Neeland, MD, is director of cardiovascular prevention and co-director of the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease for University Hospitals Harrington Heart & Vascular Institute. He is also an associate professor of medicine at Case Western Reserve University School of Medicine. He is a general cardiologist with special expertise in obesity, diabetes and cardiovascular disease.

Dr. Neeland earned his medical degree at Mount Sinai School of Medicine in New York City. He completed a residency in internal medicine and was chief medical resident at Emory University School of Medicine in Atlanta, and then completed a combined clinical and research fellowship in cardiovascular medicine at UT Southwestern Medical Center in Dallas. He also holds a certificate in translational medicine from Emory's Laney Graduate School. Certified by the American Board of Internal Medicine in both internal medicine and cardiovascular diseases, he also holds a subspecialty certification in adult echocardiography from the National Board of Echocardiography.

Dr. Neeland is an active clinical and translational investigator with funding from the National Institutes of Health and industry. He has published over 80 scholarly articles and delivered a number of national, international and regionally invited lectures. He is a reviewer for many respected journals, including Circulation, for which he currently serves as an associate editor and section editor for Bridging Disciplines.

Dr. Neeland is a Fellow of the American Heart Association and serves on several national committees with the American Heart Association. Dr. Neeland is a member of professional organizations that include the AHA Council on Epidemiology and Prevention and the Council on Lifestyle and Cardiometabolic Health; American College of Cardiology; and American Society for Preventive Cardiology.

Featured Videos

Watch to find out more about this University Hospitals provider.

Patient Experience Reviews

4.8 out of 5
- based on 100 Ratings
(5)
2/1/2024

I saw Dr Neeland because of the result of the scan provided by UH, it was high. After vitals and getting a satisfactory EKG, he indicated that the scan was not really geared toward elderly people. However, upon examining my records he is concerned with kidney function. I will folios thru with him on this.

(5)
2/1/2024

The entire team I'm working with are fantastic!!

(5)
2/1/2024

Excellent, Dr. Neeland is the absolutely the best in his specialty.Thank you & your team for literally saving my Life

(5)
2/1/2024

Good

(5)
1/1/2024

I was very happy with the care I received from Dr. Neeland. It was my first visit with him.

(5)
1/1/2024

This doctor is great, very patient and listens to my problem

(5)
12/1/2023

Very nice and personable

(5)
12/1/2023

This was my first meeting with the provider, who replaces another physician who had been my cardiologist for several years until he moved to another position in September of this year. I feel very comfortable with my new provider and respect his competence and professionalism.

(5)
9/1/2023

Good

(5)
9/1/2023

Dr. Neeland is an exceptional physician, extremely knowledgeable, caring and a gentleman!

(5)
8/1/2023

The care I received from the provider and his staff was excellent.

(5)
8/1/2023

This office is excellent.

(5)
8/1/2023

Very professional service. Thank You

(5)
7/1/2023

I always receive prompt and excellent service from this dr

(5)
6/1/2023

Very nice experience. Caring!

(5)
6/1/2023

Professional at it's best. Very in depth!

(5)
5/1/2023

Excellent care from Dr, nurse and admin staff! Couldn't he better!! Thank you

(5)
5/1/2023

Dr. Neeland has a great bedside manner. He is simple and to the point but cares about my medical issue and how it is effecting me. I would highly recommend him.

Related Blog Articles

Illustration of cholesterol plaque in clogged artery

Is Coronary Calcium Scoring Right for You? 4 Things to Know

While most people rely on their blood pressure or cholesterol numbers to manage their heart health, another test may be even better.

White pills spilling out of prescription bottle

First Drug to Prevent Heart Disease Is Approved

For the first time, an anti-inflammatory drug is on the market to prevent heart attacks and stroke.

How Heart Disease Affects the Kidneys

The heart and kidneys share a special, life-sustaining connection, so that what’s good or bad for one is generally good or bad for the other.

A young woman sleeping in bed

Why Sleep Is Essential for Heart Health

Though many people don’t realize it, sleep is just as important as your blood pressure or cholesterol level for heart health.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Ian Neeland did not disclose any Outside Relationships with Industry.